APA (7th ed.) Citation

Shao, G. (2022). Pharmacological analysis of Empagliflozin: Acting through the CaMKII pathway in type 2 diabetes and acute cardiovascular events. PLoS ONE, 17(6), 1. https://doi.org/10.1371/journal.pone.0270152

Chicago Style (17th ed.) Citation

Shao, Guangyao. "Pharmacological Analysis of Empagliflozin: Acting Through the CaMKII Pathway in Type 2 Diabetes and Acute Cardiovascular Events." PLoS ONE 17, no. 6 (2022): 1. https://doi.org/10.1371/journal.pone.0270152.

MLA (9th ed.) Citation

Shao, Guangyao. "Pharmacological Analysis of Empagliflozin: Acting Through the CaMKII Pathway in Type 2 Diabetes and Acute Cardiovascular Events." PLoS ONE, vol. 17, no. 6, 2022, p. 1, https://doi.org/10.1371/journal.pone.0270152.